These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35098746)

  • 81. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial.
    Tzikas A; Samaras A; Kartas A; Vasdeki D; Fotos G; Dividis G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Karvounis H; Giannakoulas G
    Eur Heart J Cardiovasc Pharmacother; 2021 Apr; 7(FI1):f63-f71. PubMed ID: 32339234
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
    Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
    [TBL] [Abstract][Full Text] [Related]  

  • 86. What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?
    Hung A; Perfetto EM
    J Manag Care Spec Pharm; 2016 Jul; 22(7):773-8. PubMed ID: 27348277
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Is the Currently Used Prescription Adjudication Date a Good Proxy for Calculating Medication Refill Adherence?
    Lester CA; Look KA; Chui MA
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1311-1317. PubMed ID: 27783554
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Real-world adherence to oral anticoagulants in atrial fibrillation].
    Simonyi G; Paksy A; Várnai R; Medvegy M
    Orv Hetil; 2020 May; 161(20):839-845. PubMed ID: 32364687
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
    Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
    PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
    Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
    Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment.
    Chen Q; Baek J; Goldberg R; Tjia J; Lapane K; Alcusky M
    J Am Geriatr Soc; 2023 Oct; 71(10):3071-3085. PubMed ID: 37466267
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients.
    van Breugel HN; Gelsomino S; Lozekoot PW; Accord RE; Lucà F; Parise O; Crijns HJ; Maessen JG
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):313-20. PubMed ID: 24336783
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impact of Hospitalization and Medication Switching on Post-discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation.
    Pham Nguyen TP; Chen Y; Thibault D; Leonard CE; Hennessy S; Willis A
    Pharmacotherapy; 2020 Oct; 40(10):1022-1035. PubMed ID: 32869324
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
    Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quality compensation programs: are they worth all the hype? A comparison of outcomes within a Medicare advantage heart failure population.
    Esse T; Serna O; Chitnis A; Johnson M; Fernandez N
    J Manag Care Pharm; 2013 May; 19(4):317-24. PubMed ID: 23627577
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Use of High-Risk Medications Among Older Adults Enrolled in Medicare Advantage Plans vs Traditional Medicare.
    Figueroa JF; Dai D; Feyman Y; Garrido MM; Tsai TC; Orav EJ; Frakt AB
    JAMA Netw Open; 2023 Jun; 6(6):e2320583. PubMed ID: 37368399
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The effects of coding intensity in Medicare Advantage on plan benefits and finances.
    Jacobs PD; Kronick R
    Health Serv Res; 2021 Apr; 56(2):178-187. PubMed ID: 33165932
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer.
    Yu LY; Liu YW; Chou TY; Liu YC; Su PF; Liu PY
    Rev Cardiovasc Med; 2022 Jul; 23(7):242. PubMed ID: 39076927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.